The story of Sildenafil presents a intricate picture for those considering investment. While the initial release generated massive gains, the expiration of its patent opened the avenue to off-brand competitors, https://bookmarkinginfo.com/story21594431/sildenafil-and-big-pharma-a-volatile-opportunity